Last Updated on January 6, 2024 by The Health Master
BDR Pharma has entered into a royalty-free, limited and non-exclusive voluntary licensing agreement with Eli Lilly and Company, for the manufacturing and distribution of baricitinib for the treatment of C-19 in India.
Baricitinib received restricted emergency use approval, for use in combination with remdesivir, for treatment of suspected or laboratory-confirmed coronavirus disease 2019 (C-19) in hospitalized adults and pediatric patients two years of age or older, requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
![Medicine Tablet](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_341,h_227/https://thehealthmaster.com/wp-content/uploads/2020/10/tablets-4013077_640.jpg)
Lilly received permission for restricted emergency use from the Central Drugs Standard Control Organization (CDSCO), a division of the Ministry of Health.
“We are swiftly working to ensure high-quality manufacturing and equitable access of Baricitinib for C-19 in India. We will continue to explore other possible initiatives to support patients and the healthcare system in India.” – Luca Visini, MD, India Subcontinent, Lilly India
Commenting on the development and the royalty-free non-exclusive voluntary license with Lilly, Dharmesh Shah, Chairman, BDR Pharmaceuticals, said, “We hope this collaboration will address more unmet medical needs by broadening and deepening the discovery and development of C-19 treatments options.”
BDR has applied for restricted emergency use approval with the Drug Controller General of India (DCGI) for baricitinib for C-19 in India. Lilly had recently announced seven voluntary license agreements with major local generic drug manufacturers in India for the production of the same.
Also read:
Two held for selling drugs in black market
NPPA directs Pulse Oximeter & Oxygen Concentrators to submit MRP
Black Fungus: AIIMS to develop Guidelines for treatment
DTAB dismisses proposal on labeling of drugs non-vegetarian origin with red…
DRDO launches anti-C-19 drug 2-DG
Home care package for C-19 patients launched
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: